About Us

Stacey is a leader in medical technology with 20 years of experience in medical device research, development and commercialization. Prior to joining the team, Stacey was the Chief Commercial Officer at Butterfly Network, leading planning, organization, sales and marketing. She has also held positions as President of Medtronic’s Neurovascular Operating Unit and as Vice President of Global Medical Affairs and Clinical Affairs at Covidien’s Neurovascular Division. Stacey spent her early career in a variety of clinical development roles at Kinetic Concepts and began her career in critical care and trauma nursing, nursing education, and directed the human subject research program for Texas Tech University Health Sciences Centers.

Dr. Sorli is an expert in the field of metabolic disorders including diabetes management.  He has held leadership positions at Acerus Pharmaceutical and Sanofi where he led strategy and execution of all Medical Affairs activities across a broad product portfolio.  Dr. Sorli is board certified in Endocrinology, Diabetes and Metabolism, and Internal Medicine and led The Center of Excellence in Diabetes and Metabolism,  a clinical research center and metabolic surgery program in Billings, MT.  He is a nationally and internationally recognized researcher and presenter on the topics of Type 2 Diabetes, Obesity, Metabolic Disease, and Metabolic Syndrome.

Krissy Wright brings 25 years of accounting and finance expertise to Endogenex, where she serves as Chief Financial Officer. She joined Endogenex in September 2024 after serving as CFO at Cleerly, a digital healthcare innovator in heart disease treatment. Previously, she held key leadership roles at Medtronic, including Vice President and General Manager of the Brain Modulation business and CFO for the Neuromodulation Operating Unit. Krissy began her career at PricewaterhouseCoopers in Audit, Assurance, and Transaction Services. She serves on the Board of Directors for Paragon28.
Krissy holds a B.S. in Accounting from the University of Minnesota and an M.B.A. from Duke University’s Fuqua School of Business.

Lian brings 20+ years of clinical affairs and leadership experience to the Endogenex team. Her prior leadership roles include VP of clinical affairs at both BAROnova and TriReme Medical, Inc., and medical director/VP of clinical research and education at VNUSMedical Technologies (acquired by Covidien). Earlier in her career, Lian was an assistant professor at Loyola University of Chicago and a practicing vascular surgeon in Shanghai, China.

Melanie has over 20 years of medical industry experience specializing in regulatory strategy, compliance and global regulatory affairs. Prior to joining Endogenex, she held regulatory positions at Osprey Medical, American Medical Systems, Endo Pharmaceutical (AMS) and St. Jude Medical. Melanie spent 8 years as an intensive/critical care RN. She holds a BSN from the University of Minnesota and an MBA from the University of Phoenix.

Matt brings two decades of design, development, and technical leadership expertise in the medical device industry. Before joining Endogenex he held positions of increasing responsibility at Boston Scientific and Cardiovascular Systems, Inc. (acquired by Abbott, Inc.) where he led new product development for a portfolio of 510(k) and PMA medical devices with a scope spanning research, development, manufacturing, reliability and program management.

Matt received a BSc Degree in Materials Sciences and Engineering from Iowa State University and an MBA from Augsburg College.